Showing results (1351-1360 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|December 27, 2024
Prognostic and predictive impact of NOTCH1 mutation in chronic lymphocytic leukemia: a systematic reviewVeronica Guglielmana, Davide RossiLeukemia & Lymphoma|December 3, 2024
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicityMaja Dam Andersen, Katharina Wolter, Marie Hairing Enemark, et al.Leukemia & Lymphoma|November 29, 2024
Blinatumomab for the treatment of acute lymphoblastic leukemia in a real-world setting: clinical vignettesShilpa Paul, Elias Jabbour, E Dan Nichols, et al.Leukemia & Lymphoma|November 29, 2024
Clinical trials in early-stage CLL: what has been learned and what's next?Manuela A Hoechstetter, Clemens-Martin WendtnerLeukemia & Lymphoma|November 29, 2024
Molecular landscape and clinical outcome of SRSF2/TET2 Co-mutated myeloid neoplasmsSamuel G Cockey, Hailing Zhang, Mohammed Hussaini, et al.Leukemia & Lymphoma|December 17, 2024
ML385, a selective inhibitor of Nrf2, demonstrates efficacy in the treatment of adult T-cell leukemiaChie Ishikawa, Naoki MoriLeukemia & Lymphoma|December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trialCaspian Oliai, Sunmin Park, Lloyd E Damon, et al.Leukemia & Lymphoma|December 11, 2024
Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioningEvgenii Shumilov, Lena Levien, Paolo Mazzeo, et al.Leukemia & Lymphoma|November 19, 2024
Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AMLAbdulrahman Alhajahjeh, Kishan K Patel, Rory M Shallis, et al.Leukemia & Lymphoma|November 11, 2024
FDA-approved disulfiram induces ferroptosis via alteration of redox balance and lipid peroxidation and overcomes carfilzomib resistance in multiple myelomaCaglar Arkan, Dilara Akcora-YildizPageof 998